{"title": "Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting - Full Text View - ClinicalTrials.gov", "author": null, "url": "https://clinicaltrials.gov/ct2/show/NCT04822844", "hostname": "clinicaltrials.gov", "description": "Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting - Full Text View.", "sitename": "ClinicalTrials.gov", "date": "2021-03-30", "cleaned_text": "Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting | The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our | |ClinicalTrials.gov Identifier: NCT04822844| | | Recruitment Status : Completed First Posted : March 30, 2021 Last Update Posted : July 2, 2021 - Study Details [Tabular View](/ct2/show/record/NCT04822844) [No or |Postoperative Nausea and Vomiting the Effect of Postoperative Nausea and Vomiting| |Actual Study Start Date :||April |Actual Primary Date :||June Aromatherapy with Essential Oil | Within 5 minutes of arrival at the PACU, the PACU nurse will proactively offer the patient a 2x2 gauze with two drops of essential oil (patient's choice of ginger or lavender essential oil) for all patients who have opted to participate, regardless of their nausea and vomiting status. Participating patients will continue to use the essential oil during their stay in the PACU, which is typically 45-60 minutes. | Other: Lavender Essential Oil | Within 5 minutes of arrival at the PACU, the PACU nurse will proactively offer the patient a 2x2 gauze with two drops of essential oil (patient's choice of ginger or lavender essential oil) for all patients who have opted to participate, regardless of their nausea and vomiting status. Participating patients will continue to use the essential oil during their stay in the PACU, which is typically 45-60 minutes. Other: Ginger Essential Oil Within 5 minutes of arrival at the PACU, the PACU nurse will proactively offer the patient a 2x2 gauze with two drops of essential oil (patient's choice of ginger or lavender essential oil) for all patients who have opted to participate, regardless of their nausea and vomiting status. Participating patients will continue to use the essential oil during their stay in the PACU, which is typically 45-60 minutes. - Number of Post-Operative Nausea and Vomiting Episodes While in the PACU [ Time Frame: during stay in PACU (about 45-60 minutes) ] - PACU Length of Stay [ Time Frame: time between PACU admission and PACU discharge (about 45-60 minutes) ]PACU length of stay is the time between PACU admission and PACU discharge, measured in minutes. - Number of Participants Who Use Antiemetics While in the PACU [ Time Frame: during stay in PACU (about 45-60 minutes) ] - Patient Satisfaction as Assessed by the Press Ganey Patient Satisfaction Survey [ Time Frame: at discharge (about 1 hour after PACU admission) ]The Press Ganey Patient Satisfaction Survey is scored from 0 to 100, with a higher score indicating greater satisfaction. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, [Learn About Clinical Studies.](/ct2/about-studies/learn) |Ages Eligible for Study:||18 Years and older (Adult, Older |Sexes Eligible for Study:||All| |Accepts Healthy Volunteers:||No| Inclusion Criteria: - PACU patients who are in the main PACU setting at HCA Houston Healthcare Southeast Hospital after having undergone general anesthesia for a surgical procedure Exclusion Criteria: - patients with allergies or sensitivity to ginger or lavender essential oils - patients who wish to be excluded from the project To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): |Principal Investigator:||Julie George, of Texas Health Science Center, Houston| |Responsible Party:||Julie George, Director of Surgical Services, The University of Texas Health Science Center, Houston| |ClinicalTrials.gov Identifier:|| a U.S. FDA-regulated Device Product:||No| | aromatherapy | | Nausea | Vomiting Postoperative Nausea and Vomiting | Signs and Symptoms, Digestive | Postoperative Complications Pathologic Processes "}